Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Sorrento Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- +13 vs. Q2 2021
- Shares held
- 86.1M
- +8.95M (+11.6%) vs. Q2 2021
- Total value
- $657.9M
- −$89.7M (−12.0%) vs. Q2 2021
- New holders
- 31
- 69 more added
- Sold out
- 18
- 52 more reduced
4 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $70 |
| Q1 2026 | 4 | $380 |
| Q4 2025 | 5 | $82 |
| Q3 2025 | 4 | $20 |
| Q2 2025 | 2 | $6 |
| Q1 2025 | 4 | $4 |
| Q4 2024 | 5 | $66 |
| Q3 2024 | 4 | $287 |
| Q2 2024 | 5 | $826 |
| Q1 2024 | 7 | $704 |
| Q4 2023 | 9 | $13.9K |
| Q3 2023 | 9 | $6.42K |
| Q2 2023 | 9 | $26.1K |
| Q1 2023 | 34 | $1.58M |
| Q4 2022 | 224 | $180.7M |
| Q3 2022 | 233 | $260.2M |
| Q2 2022 | 229 | $308.5M |
| Q1 2022 | 235 | $301.7M |
| Q4 2021 | 234 | $432.2M |
| Q3 2021 | 221 | $657.9M |
| Q2 2021 | 212 | $750.9M |
| Q1 2021 | 231 | $641.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Sorrento Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 419,200 | $3.20M | 0.00% | +93,400+28.7% | Added |
| UBS Group AG | 479,619 | $3.66M | 0.00% | +324,010+208.2% | Added |
| Goldman Sachs Group Inc | 597,766 | $4.56M | 0.00% | +20,023+3.5% | Added |
| Swiss National Bank | 603,300 | $4.60M | 0.00% | +16,300+2.8% | Added |
| Susquehanna International Group, LLP | 649,089 | $4.95M | 0.01% | −562,904−46.4% | Reduced |
| Norges Bank | 712,535 | $5.44M | 0.00% | +712,535 | New |
| Schroder Investment Management Group | 714,821 | $5.45M | 0.01% | −142,476−16.6% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 786,986 | $6.00M | 0.02% | +154,327+24.4% | Added |
| Morgan Stanley | 861,269 | $6.57M | 0.00% | −52,040−5.7% | Reduced |
| Wells Fargo & Company | 925,445 | $7.06M | 0.00% | +98,912+12.0% | Added |
| Bank of New York Mellon Corp | 1,162,385 | $8.87M | 0.00% | +149,208+14.7% | Added |
| Nuveen Asset Management, LLC | 1,089,945 | $8.99M | 0.00% | −125,802−10.3% | Reduced |
| Sabby Management, LLC | 1,698,107 | $13.0M | 2.84% | +500,131+41.7% | Added |
| Charles Schwab Investment Management Inc | 2,032,750 | $15.5M | 0.01% | +302,190+17.5% | Added |
| Northern Trust Corp | 2,916,760 | $22.3M | 0.00% | +61,983+2.2% | Added |
| JPMorgan Chase & Co | 2,935,011 | $22.4M | 0.00% | +367,680+14.3% | Added |
| D. E. Shaw & Co., Inc. | 2,952,835 | $22.5M | 0.03% | +1,142,466+63.1% | Added |
| Geode Capital Management, LLC | 5,059,333 | $38.6M | 0.01% | +653,387+14.8% | Added |
| State Street Corp | 12,287,375 | $93.8M | 0.00% | +2,054,848+20.1% | Added |
| Vanguard Group Inc | 15,506,493 | $118.3M | 0.00% | +1,376,502+9.7% | Added |
| BlackRock Inc. | 20,867,671 | $159.2M | 0.00% | +1,749,749+9.2% | Added |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −329,434−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −171,293−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Sante Capital Fund, LP | 0 | $0 | 0.00% | −80,414−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −76,327−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −49,546−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −40,784−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −26,973−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −21,028−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −11,481−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −6,668−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −4,426−100.0% | Sold out |
| Paradigm, Strategies in Wealth Management, LLC | 0 | $0 | 0.00% | −1,590−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Farmers & Merchants Trust Co of Chambersburg PA | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Mayo Clinic | – | – | – | – | Not filed |
| QS Investors, LLC | – | – | – | – | Not filed |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |